Diabetes Mellitus, Type 2: all 9,590 studies
Page 19 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in HumansCompletedNCT03077360Not applicableResults posted
- Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)CompletedNCT03074630Phase 4Results posted
- Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital SignCompletedNCT03068273Not applicableResults posted
- Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM PatientsTerminatedNCT03067480Not applicableResults posted
- Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With MetforminCompletedNCT03066830Phase 3Results posted
- Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in ChinaCompletedNCT03064841Results posted
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)CompletedNCT03061214Phase 3Results posted
- Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 DiabetesTerminatedNCT03053518Not applicableResults posted
- Efficacy of Mifepristone in Males With Type 2 Diabetes MellitusTerminatedNCT03052400Phase 2Results posted
- Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome PathologiesCompletedNCT03047447Not applicableResults posted
- Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes PatientsCompletedNCT03039569Not applicableResults posted
- Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 DiabetesCompletedNCT03037528Not applicableResults posted
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 DiabetesTerminatedNCT03029351Phase 4Results posted
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With InsulinCompletedNCT03021187Phase 3Results posted
- A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT03018938Phase 4Results posted
- Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 DiabetesCompletedNCT03018028Phase 3Results posted
- Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 DiabetesCompletedNCT03015220Phase 3Results posted
- Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes MellitusCompletedNCT03014479Phase 4Results posted
- Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 DiabetesCompletedNCT03014011Not applicableResults posted
- Glargine U300 Hospital TrialCompletedNCT03013985Phase 4Results posted
- Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes MellitusCompletedNCT03010683Not applicableResults posted
- Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 DiabetesCompletedNCT03005288Phase 2Results posted
- Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot UlcersCompletedNCT03002155Not applicableResults posted
- Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical PracticeTerminatedNCT02989649Results posted
- Paradoxical Stimulation of Hepatic Glucose Production With DapagliflozinCompletedNCT02984644Phase 3Results posted
- Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism SubjectsCompletedNCT02981966Phase 4Results posted
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMCompletedNCT02981069Phase 4Results posted
- diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)CompletedNCT02980978Not applicableResults posted
- Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)CompletedNCT02973477Phase 4Results posted
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusCompletedNCT02973321Phase 2Results posted
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyCompletedNCT02973100Phase 2Results posted
- Blueberry Consumption and Type 2 DiabetesCompletedNCT02972996Not applicableResults posted
- Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)CompletedNCT02971202Phase 1Results posted
- [11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 DiabetesCompletedNCT02967354Not applicableResults posted
- Role of Canagliflozin on CD34+ Cells in Patients With Type 2 DiabetesCompletedNCT02964585Phase 4Results posted
- LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.CompletedNCT02964247Phase 3Results posted
- Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal InsulinCompletedNCT02963922Phase 3Results posted
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesCompletedNCT02963766Phase 3Results posted
- Title: Therapeutic Targets in African-American Youth With Type 2 DiabetesCompletedNCT02960659Phase 1/2Results posted
- Epidemiologic Study Of Diabetes And Cancer RiskCompletedNCT02958995Results posted
- Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.CompletedNCT02958956Results posted
- Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinCompletedNCT02956044Phase 1Results posted
- A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes MellitusCompletedNCT02954601Phase 2Results posted
- Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 DiabetesCompletedNCT02948777Phase 4Results posted
- Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of MetforminCompletedNCT02926950Phase 3Results posted
- Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic TherapyCompletedNCT02926937Phase 3Results posted
- MedStar Health Type 2 Diabetes Pathway to ControlCompletedNCT02925312Not applicableResults posted
- Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusCompletedNCT02924064Phase 3Results posted
- Treatment of Diabetes in Patients With Systolic Heart FailureCompletedNCT02920918Phase 4Results posted
- Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart FailureCompletedNCT02917031Phase 4Results posted
- Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes MellitusCompletedNCT02916706Phase 3Results posted
- CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 DiabetesTerminatedNCT02912455Phase 4Results posted
- A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic DrugsCompletedNCT02911948Phase 3Results posted
- Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With HyperfiltrationCompletedNCT02911792Phase 4Results posted
- ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes MellitusCompletedNCT02910089Phase 4Results posted
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyCompletedNCT02906930Phase 3Results posted
- A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationCompletedNCT02906917Phase 3Results posted
- Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)CompletedNCT02906709Phase 4Results posted
- A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and HypertensionCompletedNCT02906579Phase 2Results posted
- Linagliptin Add-on to Insulin Background TherapyCompletedNCT02897349Phase 3Results posted
- Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes MellitusCompletedNCT02891382Not applicableResults posted
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes MellitusCompletedNCT02889510Phase 3Results posted
- Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic SubjectsCompletedNCT02886884Phase 1/2Results posted
- Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)CompletedNCT02879383Not applicableResults posted
- Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes MellitusCompletedNCT02871882Phase 2Results posted
- Anti-inflammatory Effects of the FiberCompletedNCT02868788Not applicableResults posted
- Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 InhibitorsCompletedNCT02864914Results posted
- COMRADE: Collaborative Care Management for Distress and Depression in Rural DiabetesCompletedNCT02863523Not applicableResults posted
- Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes MellitusCompletedNCT02863419Phase 3Results posted
- Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes MellitusCompletedNCT02863328Phase 3Results posted
- Phase 3 Alogliptin Pediatric StudyCompletedNCT02856113Phase 3Results posted
- Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.CompletedNCT02849080Phase 3Results posted
- JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes MellitusCompletedNCT02848833Results posted
- Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?CompletedNCT02846233Not applicableResults posted
- Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal ImpairmentCompletedNCT02836873Phase 3Results posted
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT02827708Phase 3Results posted
- Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy SubjectsCompletedNCT02820298Phase 1Results posted
- A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
- A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
- Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 DiabetesCompletedNCT02804932Not applicableResults posted
- Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 DiabetesCompletedNCT02796170Phase 4Results posted
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02793154Phase 4Results posted
- A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)CompletedNCT02791490Phase 3Results posted
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodCompletedNCT02787551Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 DiabetesCompletedNCT02784275Phase 2Results posted
- A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusCompletedNCT02773368Phase 3Results posted
- An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes MellitusCompletedNCT02771093Phase 4Results posted
- EndoBarrier in Obese Subjects With Type 2 Diabetes MellitusCompletedNCT02769728Not applicableResults posted
- Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedNCT02769481Phase 3Results posted
- The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 DiabetesCompletedNCT02762708Phase 2Results posted
- Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 DiabetesCompletedNCT02762578Phase 3Results posted
- Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 DiabetesCompletedNCT02762370Phase 2Results posted
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)CompletedNCT02759107Phase 1Results posted
- An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2CompletedNCT02756832Results posted
- YH1 in Poorly Controlled Type 2 DiabetesCompletedNCT02752880Phase 2/3Results posted
- Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02750930Phase 4Results posted
- A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesCompletedNCT02750410Phase 4Results posted
- Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed DyslipidemiaCompletedNCT02739984Phase 3Results posted
- Randomized Sitagliptin Withdrawal Study (MK-0431-845)CompletedNCT02738879Phase 3Results posted
- Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistCompletedNCT02738151Phase 4Results posted